RNA Editing for Personalized Diagnostics in Neuropsychiatry

Time: 1:00 pm
day: Day Two

Details:

  • Exploring how Alcediag develops RNA editing blood biomarkers powered by artificial intelligence in Mental health and neurosciences, inflammatory disease and oncology
  • Discovering EDIT-B, EDIT-B is the first blood test based on RNA editing biomarkers to be introduced in psychiatry where diagnoses are only based on clinical evaluations
  • Highlighting the efficacy of EDIT-B, it differentiates unipolar and bipolar depressed patients with a performance of over 80%. It will change the game by introducing precision medicine in psychiatry

Speakers: